There are 25 papers on advanced colorectal neoplasia in aging research: 1 trial and 19 observational studies in people, 5 reviews.
25 papers study it16 more mention it15 findings
8 new papers in 30 daysSee all 41 papers on advanced colorectal neoplasia
“Multivariate analysis showed that MAFLD was independently associated with increased ACN risk (OR = 1.20, P < 0.05).”
- Human trial1
- Humans19
Upstream
13-4 non-advanced adenomas
no changein humans1HR 0.64
1 study
3-4 non-advanced adenomas
no changein humans1HR 0.64
3-4 non-advanced adenomas were not clearly linked with advanced colorectal neoplasia in humans (vs individuals with 1-2 NAAs) (adjusted HR 0.64, 95% CI 0.18-2.23).
“the cumulative incidence and risk of metachronous ACRN in individuals with 1-2 NAAs was comparable with that in those with 3-4 NAAs (adjusted HR (95% CI), 0.64(0.18-2.23))”
Humansvs individuals with 1-2 NAAsn = 2,955
Surgical endoscopy
Associations
13Sarcopenia
upin humans2OR 1.97–2.347
2 studies
Sarcopenia
upin humans2OR 1.97–2.347
Sarcopenia is linked with a higher risk of advanced colorectal neoplasia in humans (multivariate analysis adjusting for confounding factors, ASM/BMI criteria) (OR 1.97, 95% CI 1.27-3.06).
“and advanced colorectal neoplasia (OR, 1.97; 95% CI, 1.27 to 3.06).”
Humansmultivariate analysis adjusting for confounding factors, ASM/BMI criterian = 10,676
Prevalence and associated risk of advanced colorectal neoplasia in adults with sarcopenia
The Korean journal of internal medicine
Sarcopenia is associated with advanced colorectal neoplasia in humans (Adjusted for variable confounders) (OR 2.347, 95% CI 1.311–4.202; P = 0.004).
“sarcopenia (odds ratio 2.347, 95% confidence interval 1.311-4.202; P = 0.004) were associated with an advanced colorectal neoplasia.”
HumansAdjusted for variable confoundersn = 1,270
Sarcopenia is associated with an increased risk of advanced colorectal neoplasia
International journal of colorectal disease
APCS + FIT + mSEPT9 model
upin humans1
1 study
APCS + FIT + mSEPT9 model
upin humans1
APCS + FIT + mSEPT9 model predicts advanced colorectal neoplasia in humans (high-risk population; internal bootstrap validation) (Optimism-corrected AUC 0.886; apparent AUC 0.912; sensitivity 91.1% and specificity 68.6% at cutoff 0.318).
“The optimism‐corrected AUC was 0.886 for the triple model and 0.852 for APCS + FIT”
Humanshigh-risk population; internal bootstrap validationn = 115
Annals of gastroenterological surgery
Fecal immunochemical test
upin humans1
1 study
Fecal immunochemical test
upin humans1
Fecal immunochemical test predicts advanced colorectal neoplasia in humans (high-risk population) (AUC 0.836 (95% CI, 0.762–0.910)).
“Quantitative FIT yielded an AUC of 0.836 (95% CI, 0.762–0.910).”
Humanshigh-risk populationn = 115
Annals of gastroenterological surgery
Asia-Pacific Colorectal Screening score
upin humans1
1 study
Asia-Pacific Colorectal Screening score
upin humans1
Asia-Pacific Colorectal Screening score predicts advanced colorectal neoplasia in humans (asymptomatic individuals undergoing screening colonoscopy) (1.6% vs 6.7% vs 16.0%).
“In the 825 individuals undergoing screening colonoscopy, ACN detection rates increased across APCS risk categories (average: 1.6%, moderate: 6.7%, high: 16.0%; p < 0.001).”
Humansasymptomatic individuals undergoing screening colonoscopyn = 825
Digestion
Multivariable fractional-polynomial interaction model
upin humans1
1 study
Multivariable fractional-polynomial interaction model
upin humans1
multivariable fractional-polynomial interaction model predicts advanced colorectal neoplasia in humans (derivation cohort) (AUC 0.76 (95% CI 0.72-0.81)).
“The model achieved AUCs of 0.76 (95% CI 0.72-0.81) in the derivation cohort”
Humansderivation cohortn = 715
Journal of gastroenterology and hepatology
Advanced colorectal neoplasia risk stratification model
upin humans1
1 study
Advanced colorectal neoplasia risk stratification model
upin humans1
Advanced colorectal neoplasia risk stratification model predicts advanced colorectal neoplasia in humans (AUROC = 0.870).
“The model demonstrated strong predictive performance (AUROC = 0.870) and good calibration (P = 0.929).”
Humans
Quantitative Fecal Immunochemical Test for Advanced Colorectal Neoplasia Risk Stratification
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
More on Advanced colorectal neoplasia risk stratification model
> 4 non-advanced adenomas
upin humans1HR 4.69
1 study
> 4 non-advanced adenomas
upin humans1HR 4.69
> 4 non-advanced adenomas are linked with a higher risk of advanced colorectal neoplasia in humans (vs individuals with 1-2 NAAs) (adjusted HR 4.69, 95% CI 1.51-14.6).
“and significantly lower than that in those with > 4 NAAs (adjusted HR (95% CI), 4.69(1.51-14.6))”
Humansvs individuals with 1-2 NAAsn = 2,955
Surgical endoscopy
Colorectal serrated lesion
upin humans1OR 1.94
1 study
Colorectal serrated lesion
upin humans1OR 1.94
Colorectal serrated lesion is associated with advanced colorectal neoplasia in humans (OR, 1.94; 95% CI, 1.24-3.02).
“Detection of proximal SLs was associated with synchronous advanced colorectal neoplasia (OR, 1.94; 95% CI, 1.24-3.02 and 1.90; 1.18-3.07, respectively).”
Humansn = 965
The American journal of gastroenterology
Low-grade colorectal dysplasia
upin humans1
1 study
Low-grade colorectal dysplasia
upin humans1
Low-grade colorectal dysplasia is associated with advanced colorectal neoplasia in humans (Inflammatory bowel disease; baseline low-grade dysplasia compared with no dysplasia) (aHR 3.51, 95% CI 2.77–4.45; 8.3% versus 2.3%).
“8.3% of patients with LGD (aHR, 3.51; 95% CI, 2.77-4.45).”
HumansInflammatory bowel disease; baseline low-grade dysplasia compared with no dysplasiaMedian follow-up of 13.3 yearsn = 1,031
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Indefinite colorectal dysplasia
upin humans1
1 study
Indefinite colorectal dysplasia
upin humans1
Indefinite colorectal dysplasia is associated with advanced colorectal neoplasia in humans (Inflammatory bowel disease; baseline indefinite dysplasia compared with no dysplasia) (aHR 1.85, 95% CI 1.09–3.15; 5.3% versus 2.3%).
“2.3% of patients with ND had future advanced CRN compared with 5.3% of patients with IND (aHR, 1.85; 95% CI, 1.09-3.15)”
HumansInflammatory bowel disease; baseline indefinite dysplasia compared with no dysplasiaMedian follow-up of 13.3 yearsn = 264
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association